Plasma biomarkers of clinical response during chemotherapy plus combination antiretroviral therapy (cART) in HIV+ patients with advanced Kaposi sarcoma

This study aimed to evaluate plasma concentration of selected cancer-associated inflammatory and immune-modulated cytokines in HIV+ patients with advanced Kaposi sarcoma (KS), and to explore candidate biomarkers capable of predicting clinical outcome in response to chemotherapy (CT) plus combination...

Full description

Saved in:

Bibliographic Details
Published in:	Oncotarget Vol. 6; no. 30; pp. 30334 - 30342
Main Authors:	Tedeschi, Rosamaria, Bidoli, Ettore, Bortolin, Maria Teresa, Schioppa, Ornella, Vaccher, Emanuela, De Paoli, Paolo
Format:	Journal Article
Language:	English
Published:	United States Impact Journals LLC 06-10-2015
Subjects:	Adult Anti-Retroviral Agents - therapeutic use Antigens, CD - blood Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biomarkers, Tumor - blood Chemokines - blood Clinical Research Paper Cytokines - blood Endoglin Female Granulocyte Colony-Stimulating Factor - blood Hepatocyte Growth Factor - blood HIV Infections - blood HIV Infections - diagnosis HIV Infections - drug therapy HIV Infections - mortality HIV Infections - virology Humans Kaplan-Meier Estimate Male Middle Aged Multivariate Analysis Predictive Value of Tests Proportional Hazards Models Receptors, Cell Surface - blood Remission Induction Sarcoma, Kaposi - blood Sarcoma, Kaposi - diagnosis Sarcoma, Kaposi - drug therapy Sarcoma, Kaposi - mortality Sarcoma, Kaposi - virology Time Factors Treatment Outcome Kaposi sarcoma (KS) endoglin G-CSF HGF combination antiretroviral therapy (cART)
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!